Ophthalmic Drug Dispensers Being Reclassified In US As Combo Products Get Regulatory Leeway

US FDA gives 12 month grace period for ophthalmic products once regulated as drugs to comply with requirements for combination products and temporarily exempts lower-risk constituents. Guidance specifies changes agency is making in response to Genus Medical v. FDA decision.